✦ LIBER ✦

An additive/substractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients

✍ Scribed by Sophie Capdepont; Valérie Aurillac-Lavignolle; Muriel Faure; Michel Dupon; Philippe Morlat; Jean-Marie Ragnaud; Geneviève Chêne; Hervé Fleury; Bernard Masquelier

Book ID: 116630965
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 229 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2006.01.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A triple antiretroviral regimen containi

A triple antiretroviral regimen containing stavudine and didanosine seems to be an option in the initial treatment of patients with HIV-1 infection,

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Impact of the peginterferon-α 2a and rib

Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes

✍ Torres-Cornejo, A.; Ruiz-Valderas, R.; Jimenez-Jimenez, L.; Abad-Molina, C.; Gut 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Influence of RANTES, SDF-1 and TGF-β lev

Influence of RANTES, SDF-1 and TGF-β levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy

✍ MR Boulassel; GHR Smith; MDdeB Edwardes; M Young; M Klein; N Gilmore; J MacLeod; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

P.411 The impact of age on sustained vir

P.411 The impact of age on sustained virological response in genotype 1 HIV-HCV co-infected patients receiving peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®): AIDS PEGASYS ribavirin co-infection trial (APRICOT)

✍ J. Rockstroh; F.J. Torriani; M. Rodriguez Torres; E. Lissen; A. Lazzarin; J. De 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 274 KB

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon